High Purity CAS 317318-70-0 Gw-501516 for Weight Loss

High Purity CAS 317318-70-0 Gw-501516 for Weight Loss

Basic Info:

Product Name: GW501516

CAS NO.: 317318-70-0

Alias: Cardarine

Molecular formula: C21H18F3NO3S2

Molecular weight: 453.50

Purity: 99%

Grade: Pharmaceutical Grade

Appearance: White Powder

Usage: Fat loss

Dose: The recommended dosage for GW is 10-20 mg and for 8 weeks length

Product Description:

GW501516 is the name of a Glaxo Wellcome drug (the GW stands for the company and the number

is that of the product). It is also known as GW-501,516, GW1516, GSK-516).

GW-501516 is a selective agonist with high affinity and it is very potent. Various studies on this

PPAR receptor in lab rats indicates that it regulates the various proteins that the body uses for

energy. Rats with high fat and low metabolism were given the product and they were able to

lose weight and to increase overall energy levels.

Application:

GW501516 (also known as GW-501,516, GW1516, GSK-516 and on the black market as Endurobol) is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s, was entered into clinical development as a drug candidate for metabolic diseases and cardiovascular diseases, and was abandoned in 2007 because animal testing showed that the drug caused cancer to develop rapidly in several organs.

In 2007 research was published showing that high doses of GW501516 given to mice dramatically improved their physical performance; the work was widely discussed in popular media, and led to a black market for the drug candidate and to its abuse by athletes as a doping agent. The World Anti-Doping Agency (WADA) developed a test for GW501516 and other related chemicals and added them to the prohibited list in 2009; it has issued additional warnings to athletes that GW501516 is not safe.

History:

Concerns were raised prior to the 2008 Beijing Olympics that GW501516 could be used by athletes as an ergogenic performance-enhancing drug that was not currently controlled by regulations or detected by standard tests. One of the main researchers from the study on enhanced endurance consequently developed a urine test to detect the drug, and made it available to the International Olympic Committee. The World Anti-Doping Agency (WADA) developed a test for GW501516 and other related PPARδ modulators,and added such drugs to the prohibited list in 2009.

GW501516 has been promoted on bodybuilding and athletics websites and by 2011 had already been available for some time on the black market. In 2011 it was reported to cost $1000 for 10 g.In 2012, WADA recategorised GW501516 from a gene doping compound to a "hormone and metabolic modulator".